12/17/2012 – China
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC3524164
CDA-2 (cell differentiation agent 2), a URINARY preparation
CDA-2 and its main component PHENYLACETYLGLUTAMINE (PG or PAG)
Antineoplaston AS2-5 is PHENYLACETYLGLUTAMINE (PAG or PG)
Antineoplaston AS2-1 is a 4:1 mixture of phenylacetic acid (PA) and PHENYLACETYLGLUTAMINE (PAG or PG)
Antineoplastons AS2-5 and AS2-1 are derived from Antineoplaston A10
BURZYNSKI Reference: 22.
antineoplaston AS21
http://www.plosone.org/article/info%3Adoi%2F10.1371%2Fjournal.pone.0052117
National Cancer Institute, at the National Institutes of Health cancer . gov web-site re Antineoplastons:
http://www.cancer.gov/cancertopics/pdq/cam/antineoplastons/healthprofessional/page5
PHENYLACETYLGLUTAMINE (PAG or PG)
Antineoplaston AS2-5 is PHENYLACETYLGLUTAMINE (PAG or PG)
Antineoplaston AS2-1 is a 4:1 mixture of phenylacetic acid (PA) and PHENYLACETYLGLUTAMINE (PAG or PG)
Antineoplastons AS2-5 and AS2-1 are derived from Antineoplaston A10
PHENYLACETYLGLUTAMINE (PAG or PG) and Phenylacetate (PN) are metabolites of Phenylbutyrate (PB) and are constituents of antineoplaston AS2-1
4/1994 – Dvorit D. SAMID et al.
A phase I … study of intravenous phenylacetate (PN) in patients with cancer
Cancer Res 54(7):1690-4 (1994), PMID 8137283
Cancer Res. 1994 Apr 1;54(7):1690-4
Clinical Pharmacology Branch, National Cancer Institute, NIH, Bethesda, Maryland
http://www.ncbi.nlm.nih.gov/m/pubmed/8137283
Phenylacetate (PN) elimination was accounted for by conversion to PHENYLACETYLGLUTAMINATE (PG or PAG), which was excreted in the urine
4/1995 – Dvorit D. SAMID et al.
Disposition of Phenylbutyrate (PB) and its metabolites Phenylacetate (PN) and PHENYLACETYLGLUTAMINATE (PG or PAG)
J Clin Pharmacol 35(4):368-73 (1995), PMID 7650225
J Clin Pharmacol. 1995 Apr;35(4):368-73
Pharmacy Department, National Institutes of Health, Bethesda, Maryland, USA
http://www.ncbi.nlm.nih.gov/m/pubmed/7650225
PHENYLACETYLGLUTAMINATE (PG or PAG) and Phenylacetate (PN) are metabolites of Phenylbutyrate (PB) and are constituents of AS2-1